Evidence map›Paper›PMID 42011901›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Cell Cycle Control of Nuclear Metabolism Couples Phosphatidylinositol Signaling to Histone Methylation.

Antoni Gañez-Zapater, Savvas Kourtis, Camilla Reiter Elbæk, Lorena Espinar, Carolina Toro-Márquez, Albert Coll-Manzano, Alfredo Smiriglia, Laura García-López, Laura Wiegand, Maria Guirola and 4 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Antoni Gañez-ZapaterCentre For Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Savvas KourtisCentre For Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Camilla Reiter ElbækCentre For Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Lorena EspinarCentre For Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Carolina Toro-MárquezCentre For Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Albert Coll-ManzanoCentre For Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Alfredo SmirigliaDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.
Laura García-LópezCentre For Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Laura WiegandCentre For Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Maria GuirolaCentre For Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Frédéric FontaineCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Andrea MorandiDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.
André C MüllerCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Sara SdelciCentre For Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID https://orcid.org/0000-0003-1330-4364

Funding

European Research Council 852343Generalitat de CatalunyaSpanish Ministry of Science and Innovation CEX2020-001049-SSpanish Ministry of Science and Innovation MCIN/AEI /10.13039/501100011033Spanish Plan Estatal PID2019-110598GA-I00/AEI/10.13039/501100011033Spanish Plan Estatal PID2022-141740NB-I00
6 · The paper itself

Abstract

Progression through the cell cycle requires coordinated regulation of transcription, chromatin state, and cellular metabolism. While metabolic enzymes are known to localize the nucleus and influence chromatin states, how nuclear metabolism itself oscillates during the cell cycle remains unexplored. Here, we combine a customized FUCCI-3 reporter with chromatome mass spectrometry and high-throughput imaging to systematically resolve nuclear and chromatin-associated metabolic changes across cell cycle phases. We identify phosphatidylinositol metabolism as a nuclear pathway that oscillates with the cell cycle, with PIP5K1A, PLCD3, and PLD2 showing phase-specific nuclear and chromatin dynamics. Nuclear PIP2 levels redistribute within the nucleus depending on cell cycle stage. Downregulation of PIP5K1A reduces nuclear PIP2 levels, whereas nuclear enrichment of PIP5K1A increases PIP2 abundance in the nucleus and nucleolus, functionally linking PIP5K1A nuclear localization to nuclear PIP2 synthesis. Moreover, perturbation of nuclear PIP2 synthesis alters chromatin methylation, with a pronounced impact on H4K20 monomethylation. Together, our results reveal that nuclear phosphatidylinositol metabolism is cell cycle regulated and functionally linked to chromatin methylation, establishing nuclear lipid metabolism as a previously unrecognized layer of cell cycle control.

Indexed as

Cell CycleCell NucleusHistonesPhosphatidylinositolsChromatinHumansMethylationSignal TransductionChromatinHistonesPhosphatidylinositolscell cyclechromatinepigeneticsnuclear metabolismproteomics

Identifiers

PMID42011901
PMCPMC13285136

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.